Distribution of CD4+ and CD8+ exhausted tumor-infiltrating lymphocytes in molecular subtypes of Chinese breast cancer patients

被引:8
|
作者
Shi, Feng [1 ]
Chang, Hong [1 ]
Zhou, Quan [1 ]
Zhao, Yan-Jie [2 ]
Wu, Guang-Jiang [3 ]
Song, Qing-Kun [4 ,5 ]
机构
[1] Capital Med Univ, Beijing Shijitan Hosp, Dept Pathol, Tieyi Rd 10, Beijing 100038, Peoples R China
[2] Capital Med Univ, Beijing Shijitan Hosp, Dept Med Oncol, Beijing 100038, Peoples R China
[3] Capital Med Univ, Beijing Shijitan Hosp, Dept Infect Control, Beijing 100038, Peoples R China
[4] Capital Med Univ, Beijing Shijitan Hosp, Dept Sci & Technol, Tieyi Rd 10, Beijing 100038, Peoples R China
[5] Dept Canc Epidemiol, Beijing Key Lab Canc Therapeut Vaccine, Beijing 100038, Peoples R China
来源
ONCOTARGETS AND THERAPY | 2018年 / 11卷
关键词
breast cancer; tumor-infiltrating lymphocyte; PD-1; molecular subtype; POOR-PROGNOSIS; TRIAL; CHEMOTHERAPY; SURVIVAL; PD-L1; TRASTUZUMAB; MULTICENTER; EXPRESSION;
D O I
10.2147/OTT.S168057
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Purpose: Breast cancer (BC) is the leading cancer affecting Chinese women; however, the immune microenvironment between molecular subtypes is less reported. This study aimed to investigate the distribution of tumor-infiltrating lymphocyte (TIL) subpopulations, especially exhausted CD4(+) and CD8(+). TILs in Chinese BC patients. Patients and methods: A total of 133 patients with breast invasive ductal carcinoma were recruited consecutively from January 1, 2012 to December 31, 2013, and TILs were detected in H&E-stained sections. Expression profiling of PD-1, CD4 and CD8 was determined by immunohistochemistry on 4 mu m formalin-fixed paraffin-embedded tissue sections. The distribution of TILs was analyzed based on hormone receptor status and molecular subtypes. Results: PD-1(+), CD4(+) and CD8(+). TI Ls distributed differently based on molecular subtypes. Compared to Lumina! A, triple-negative breast cancer (TNBC) patients had more PD-1(+) TILs (39/high-power field [HPF] vs 11/HPF), PD-1(+ )helper T (CD4(+)) cells (28/HPF vs 10/HPF), and PD-1(+). cytotoxic (CD8(+)) T-cells (3/HPF vs 2/HPF). Conclusion: TILs are distributed differently based on molecular subtypes. TNBC patients exhibit more PD-1(+). exhausted TILs, representing an inhibitory immune microenvironment. PD-1/PD-L1 pathway is a potential therapeutic target of TNBC.
引用
收藏
页码:6139 / 6145
页数:7
相关论文
共 50 条
  • [1] CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma
    Fukunaga, A
    Miyamoto, M
    Cho, Y
    Murakami, S
    Kawarada, Y
    Oshikiri, T
    Kato, K
    Kurokawa, T
    Suzuoki, M
    Nakakubo, Y
    Hiraoka, K
    Itoh, T
    Morikawa, T
    Okushiba, S
    Kondo, S
    Katoh, H
    [J]. PANCREAS, 2004, 28 (01) : E26 - E31
  • [2] Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer
    Mahmoud, Sahar M. A.
    Paish, Emma Claire
    Powe, Desmond G.
    Macmillan, R. Douglas
    Grainge, Matthew J.
    Lee, Andrew H. S.
    Ellis, Ian O.
    Green, Andrew R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) : 1949 - 1955
  • [3] Determination of Tumor-infiltrating CD8+ Lymphocytes in Human Ovarian Cancer
    Aust, Stefanie
    Bachmayr-Heyda, Anna
    Pils, Dietmar
    Zhao, Lijun
    Tong, Weimin
    Berger, Astrid
    Fogel, Mina
    Thalhammer, Theresa
    Sehouli, Jalid
    Horvat, Reinhard
    Zeillinger, Robert
    Castillo-Tong, Dan C.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2013, 32 (03) : 269 - 276
  • [4] CHARACTERIZATION OF THE CYTOLYTIC ACTIVITY OF CD4+ AND CD8+ TUMOR-INFILTRATING LYMPHOCYTES IN HUMAN RENAL-CELL CARCINOMA
    FINKE, JH
    RAYMAN, P
    ALEXANDER, J
    EDINGER, M
    TUBBS, RR
    CONNELLY, R
    PONTES, E
    BUKOWSKI, R
    [J]. CANCER RESEARCH, 1990, 50 (08) : 2363 - 2370
  • [5] The Prognostic Role of Tumor-infiltrating CD4 and CD8 T Lymphocytes in Breast Cancer
    Matkowski, Rafal
    Gisterek, Iwona
    Halon, Agnieszka
    Lacko, Aleksandra
    Szewczyk, Krzysztof
    Staszek, Urszula
    Pudelko, Marek
    Szynglarewicz, Bartlomiej
    Szelachowska, Jolanta
    Zolnierek, Andrzej
    Kornafel, Jan
    [J]. ANTICANCER RESEARCH, 2009, 29 (07) : 2445 - 2451
  • [6] Tumor-specific CD4+ Melanoma Tumor-infiltrating Lymphocytes
    Friedman, Kevin M.
    Prieto, Peter A.
    Devillier, Laura E.
    Gross, Colin A.
    Yang, James C.
    Wunderlich, John R.
    Rosenberg, Steven A.
    Dudley, Mark E.
    [J]. JOURNAL OF IMMUNOTHERAPY, 2012, 35 (05) : 400 - 408
  • [7] CHANGES ON DISTRIBUTION OF CD4+ CD45RA- AND CD8+ CD11- CELLS IN TUMOR-INFILTRATING LYMPHOCYTES OF RENAL-CELL CARCINOMA ASSOCIATED WITH TUMOR PROGRESSION
    IGARASHI, T
    MURAKAMI, S
    TAKAHASHI, H
    MATSUZAKI, O
    SHIMAZAKI, J
    [J]. EUROPEAN UROLOGY, 1992, 22 (04) : 323 - 328
  • [8] PD-L1, CD4+, and CD8+ Tumor-Infiltrating Lymphocytes (TILs) Expression Profiles in Melanoma Tumor Microenvironment Cells
    Caraban, Bogdan Marian
    Matei, Elena
    Cozaru, Georgeta Camelia
    Aschie, Mariana
    Deacu, Mariana
    Enciu, Manuela
    Baltatescu, Gabriela Izabela
    Chisoi, Anca
    Dobrin, Nicolae
    Petcu, Lucian
    Gheorghe, Emma
    Hangan, Laurentiu-Tony
    Rosu, Mihai Catalin
    Orasanu, Cristian Ionut
    Nicolau, Antonela-Anca
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (02):
  • [9] Radiomic models based on magnetic resonance imaging predict the spatial distribution of CD8+ tumor-infiltrating lymphocytes in breast cancer
    Jeon, Seung Hyuck
    Kim, So-Woon
    Na, Kiyong
    Seo, Mirinae
    Sohn, Yu-Mee
    Lim, Yu Jin
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [10] Tumor-infiltrating CD4+ T cells in patients with gastric cancer
    Long Yuan
    Benling Xu
    Peng Yuan
    Jinxue Zhou
    Peng Qin
    Lu Han
    Guangyu Chen
    Zhenlei Wang
    Zengci Run
    Peng Zhao
    Quanli Gao
    [J]. Cancer Cell International, 17